Skip to main content

FibroBiologics, Inc.

FBLG
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001958777

No open-market purchases or sales by FibroBiologics, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q3 2026, worth $1.25M in total; no superinvestor holds it.

Holders of 5% or more of FBLG

Holders whose latest Schedule 13D or 13G filing reports 5% or more of FibroBiologics, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of FBLG
HolderLatest formStakeChangeFirst filedLatest filingFiling
O'Heeron Pete13G18.20%6.95M sharesNewFeb 12, 20251 filingFeb 12, 2025SEC
Armistice Capital, LLC13G/A9.99%666.2K shares0.00 ppfrom 9.99%Aug 14, 20262 filingsNov 16, 2026SEC
Khoja Hamid13D7.50%630.0K sharesNewSep 17, 20261 filingSep 17, 2026SEC
Newlin Michael F.13G5.58%2.13M sharesNewJun 6, 20251 filingJun 6, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

9 Schedule 13D and 13G filings on FibroBiologics, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on FBLG
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 16, 202612:09 PM ETArmistice Capital, LLCand 1 other13G/A9.99%666.2K shares0.00 ppfrom 9.99%Sep 30, 2026SEC
Sep 17, 20264:01 PM ETKhoja Hamid13D7.50%630.0K sharesNewSep 15, 2026SEC
Aug 14, 202610:13 AM ETArmistice Capital, LLCand 1 other13G9.99%739.0K sharesNewJun 30, 2026SEC
Apr 9, 20264:30 PM ETLind Global Fund III LPand 2 others13G4.99%230.2K sharesNewBelow 5%Apr 2, 2026SEC
Jul 17, 20257:54 PM ETBlackRock, Inc.13G/A2.00%750.9K shares−3.10 ppfrom 5.10%Below 5%Jun 30, 2025SEC
Jun 6, 20253:13 PM ETNewlin Michael F.13G5.58%2.13M sharesNewAug 9, 2024SEC
Feb 12, 20254:01 PM ETO'Heeron Pete13G18.20%6.95M sharesNewJan 31, 2024SEC
Jan 30, 202512:43 PM ETBlackRock, Inc.13G/A5.10%1.79M shares0.00 ppfrom 5.10%Dec 31, 2024SEC
Jan 29, 20254:43 PM ETBlackRock, Inc.13G5.10%1.79M sharesNewDec 31, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell FibroBiologics, Inc. shares.

No Form 144 notices for FibroBiologics, Inc. are on file.